Evidence map›Paper›PMID 39398093›Full record

ArticleGhana medical journal2024

Management and associated outcomes of COVID-19 infection among Ghanaian autoimmune rheumatic disease patients.

Dzifa Dey, Bright Katso, Derrick Nyame, Saudatu Issaka, Partrick Adjei

Abstract read
In one paragraph

Article in Ghana medical journal, 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

5 authors.

Dzifa DeyDepartment of Medicine and Therapeutics, University of Ghana Medical School, Legon, Accra, Ghana.
Bright KatsoRheumatology Unit, Department of Medicine and Therapeutics, Korle-Bu Teaching Hospital, Accra, Ghana.
Derrick NyameDepartment of Medicine and Therapeutics, University of Ghana Medical School, Legon, Accra, Ghana.
Saudatu IssakaRheumatology Unit, Department of Medicine and Therapeutics, Korle-Bu Teaching Hospital, Accra, Ghana.
Partrick AdjeiDepartment of Medicine and Therapeutics, University of Ghana Medical School, Legon, Accra, Ghana.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Objective: This study assessed the prevalence of infection, management strategies and associated disease outcomes of COVID-19 among Autoimmune Rheumatic Disease (AIRD) patients in a teaching hospital in Ghana. Design: This was a retrospective cross-sectional study. Setting: Rheumatology Unit, Korle Bu Teaching Hospital. Participants: Autoimmune Rheumatic Disease patients. Results: Thirty-one (31) out of approximately 1700 AIRD patients in the unit tested positive for COVID-19, registering a COVID-19 prevalence of 1.82%. The majority, 25(80.6%), were females with a mean ± SD age of 41.7 ± 12.8 years. Systemic lupus erythematosus was the most affected autoimmune rheumatic condition, reporting fever as the commonest COVID-19-related symptom. Most participants, 22(71%), were managed by the "self-isolation"/home management" strategy. In comparison, 7(22.5%) were monitored at the hospital, with both strategies having resulted in complete recovery. The remaining 2(6.5%) patients who managed under "intensive care unit" strategy resulted in mortality. Conclusion: These findings highlight the relatively low frequency of COVID-19 infection among AIRD patients, the encouraging recovery, and the low severe disease rates observed within this cohort. Additionally, the outcome of self-isolation and home management strategies underscore the importance of personalised approaches to COVID-19 management in this population. Funding:

Indexed as

Autoimmune DiseasesCOVID-19Rheumatic DiseasesSARS-CoV-2AdultCross-Sectional StudiesFemaleGhanaHumansLupus Erythematosus, SystemicMaleMiddle AgedPrevalenceRetrospective StudiesAutoimmune Rheumatic Disease (AIRD)COVID-19ManagementOutcomeSelf-isolation

Identifiers

PMID39398093
PMCPMC11465720

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.